Traitements des lymphomes T périphériques
Reference66 articles.
1. Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26: 4124–30
2. Swerdlow SH, Campo E, Harris NL, et al. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC
3. Weisenburger DD, Savage KJ, Harris NL, et al. (?) Peripheral T-cell lymphoma, nototherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 117: 3402–8
4. Jaccard A, Gachard N, Marin B, et al. (?) Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood 117: 1834–9
5. Yamaguchi M, Kwong YL, Kim WS, et al. (?) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 29: 4410–6